Monitoring airway inflammation after allergen challenge by measuring 8-isoprostane in exhaled breath condensate
I. Badiu, S. Sciascia, E. Heffler, G. Guida, F. De Renzis, C. Quaccia, L. Bommarito, C. Bucca, G. Rolla, L. Brussino (Turin, Italy)
Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Badiu, S. Sciascia, E. Heffler, G. Guida, F. De Renzis, C. Quaccia, L. Bommarito, C. Bucca, G. Rolla, L. Brussino (Turin, Italy). Monitoring airway inflammation after allergen challenge by measuring 8-isoprostane in exhaled breath condensate. Eur Respir J 2010; 36: Suppl. 54, 5352
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Exhaled breath condensate pH standardised for CO2 partial pressure Source: Eur Respir J 2007; 29: 496-501 Year: 2007
Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002
Monitoring of 24-hours variation of leukotrienes in exhaled breath condensate Source: Annual Congress 2007 - Acute and chronic effects of air pollution Year: 2007
Ozone-induced airway inflammation and its attenuation by corticosteroids are detectable in sputum samples but not in exhaled breath condensate Source: Eur Respir J 2004; 24: Suppl. 48, 577s Year: 2004
Levels of 8-isoprostane and LTB4 in exhaled breath condensate (EBC) in seasonal allergic rhinitis. Effect of therapy and allergen exposure Source: Eur Respir J 2004; 24: Suppl. 48, 678s Year: 2004
Exercise-induced changes in concentrations of cysteinyl-leukotrienes in exhaled breath condensate Source: Eur Respir J 2004; 24: Suppl. 48, 680s Year: 2004
Exhaled breath condensate: 8-isoprostane and eicosanoids Source: Eur Respir Monogr 2010; 49: 196-206 Year: 2010
Markers of airway diseases in exhaled breath condensate and their clinical value Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008
8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002
Increased exhaled breath condensate cysteinyl leukotriene concentration in exercise-induced bronchoconstriction Source: Annual Congress 2011 - Clinical application of exhaled biomarkers Year: 2011
Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation Source: Eur Respir J 2004; 24: 1011-1017 Year: 2004
Inflammatory mediators in exhaled breath condensate, induced sputum and saliva Source: Eur Respir J 2004; 24: Suppl. 48, 678s Year: 2004
Relationship between acidity of exhaled breath condensate, lung function and airway inflammation in asthmatic children Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007
Increased 8-isoprostane in the exhaled breath condensate of down patients Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004